You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HRPC

Showing 1 - 25 of 141
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Retinitis Pigmentosa Trial in Spain, United Kingdom, United States (hRPC)

Active, not recruiting
  • Retinitis Pigmentosa
  • hRPC
  • Phoenix, Arizona
  • +4 more
Jan 19, 2022

Prostate Cancer Trial in United States (Vinflunine)

Completed
Has Results
  • Prostate Cancer
  • Fort Myers, Florida
  • +11 more
Dec 14, 2021

Biomarkers of Response to Taxotere in HRPC. ICORG 08-08, V2

Completed
  • Metastatic Cancer
  • Prostate Cancer
  • Dublin, Ireland
  • +4 more
Nov 16, 2020

Hormone Refractory Prostate Cancer Trial in United States (Docetaxel, TroVax)

Terminated
  • Hormone Refractory Prostate Cancer
  • San Bernardino, California
  • +6 more
Oct 8, 2020

Prostate Cancer Trial in Los Angeles (carboplatin, paclitaxel)

Completed
Has Results
  • Prostate Cancer
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center at UCLA
Aug 17, 2020

Hormone Refractory Prostate Cancer Trial in United States (LBH589)

Terminated
  • Hormone Refractory Prostate Cancer
  • Boston, Massachusetts
  • +4 more
Dec 16, 2020

Prostate Cancer Trial in Los Angeles, Seattle (docetaxel, erlotinib HCl)

Completed
  • Prostate Cancer
  • Los Angeles, California
  • +2 more
Jul 30, 2020

Acute Coronary Syndrome, Ischemic Heart Disease Trial in Shanghai, Seoul (CCTA-derived high risk plaque characteristics,

Active, not recruiting
  • Acute Coronary Syndrome
  • Ischemic Heart Disease
  • CCTA-derived high risk plaque characteristics
  • CFD-derived hemodynamic parameters
  • Shanghai, China
  • +1 more
Sep 6, 2022

Prostate Cancer Trial in United States (Docetaxel, Docetaxel and GM-CSF)

Completed
Has Results
  • Prostate Cancer
  • San Francisco, California
  • +3 more
Oct 29, 2019

Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells)

Completed
  • Retinitis Pigmentosa
  • human retinal progenitor cells
  • Irvine, California
  • +2 more
Aug 8, 2022

Liver Cancer Trial in France (Oxaliplatin, Irofulven)

Completed
  • Liver Cancer
  • Bordeaux, France
  • +6 more
Nov 24, 2021

Hormone Refractory Prostate Cancer, Bone Metastases Trial (Radium-223 dichloride (BAY88-8223))

Completed
  • Hormone Refractory Prostate Cancer
  • Bone Metastases
  • Radium-223 dichloride (BAY88-8223)
  • (no location specified)
Dec 17, 2018

Prostate Cancer Trial in Canada, United States (LBH589 (i.v. panobinostat))

Completed
  • Prostate Cancer
  • LBH589 (i.v. panobinostat)
  • Rockville, Maryland
  • +8 more
Dec 16, 2020

Prostate Cancer Patients Trial in Qingdao, Shanghai (Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin)

Recruiting
  • Prostate Cancer Patients
  • Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin
  • Qingdao, Shandong, China
  • +1 more
May 3, 2022

Prostate Cancer Trial in Switzerland (cetuximab, docetaxel)

Completed
  • Prostate Cancer
  • Aarau, Switzerland
  • +20 more
May 13, 2019

Coronary CT Angiography in Coronary Artery Disease

Recruiting
  • Coronary Artery Disease
  • Coronary CT angiography
  • Shanghai, China
    Shanghai Zhongshan Hospital
May 18, 2022

Prostatic Tumors Trial in London, Ottawa, Toronto (Degarelix)

Terminated
  • Prostatic Neoplasms
  • London, Ontario, Canada
  • +2 more
May 5, 2020

Acute Respiratory Infection Trial in Worldwide (Nasal Swab Sample)

Recruiting
  • Acute Respiratory Infection
  • Nasal Swab Sample
  • Birmingham, Alabama
  • +232 more
Aug 2, 2022

Castration Resistant Prostate Cancer Trial in Fountain Valley (NRX 194204)

Completed
Has Results
  • Castration Resistant Prostate Cancer
  • NRX 194204
  • Fountain Valley, California
    Lalita Pandit, MD
Apr 23, 2021

Prostate Cancer Trial in United States (TOK-001)

Completed
  • Prostate Cancer
  • Los Angeles, California
  • +7 more
Sep 2, 2020

Myelofibrosis, Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Worldwide (Pelabresib, Ruxolitinib, Placebo)

Recruiting
  • Myelofibrosis
  • +3 more
  • Birmingham, Alabama
  • +148 more
Oct 10, 2022

Pregnancy; Fetomaternal Hemorrhage Trial in Brazil (Immunoglobulin Anti-RhD)

Suspended
  • Pregnancy; Fetomaternal Hemorrhage
  • Immunoglobulin Anti-RhD
  • Fortaleza, Ceara, Brazil
  • +4 more
Aug 17, 2018

Hormone Refractory Prostate Cancer, Recurrent Prostate Cancer Trial in Canada, United States (cediranib maleate, dasatinib)

Completed
Has Results
  • Hormone Refractory Prostate Cancer
  • Recurrent Prostate Cancer
  • Peoria, Illinois
  • +7 more
Jul 9, 2018

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Duarte (saracatinib, laboratory biomarker analysis)

Completed
Has Results
  • Hormone-resistant Prostate Cancer
  • Recurrent Prostate Cancer
  • Duarte, California
    City of Hope
Mar 21, 2018

Castration Resistant Prostate Cancer Trial in Germany (SOM230)

Completed
  • Castration Resistant Prostate Cancer
  • Berlin, Germany
  • +3 more
Dec 17, 2020